Life Expectancy after Bariatric Surgery in the Swedish Obese Subjects Study

This study compared long-term mortality and life expectancy among patients who underwent bariatric surgery or received usual obesity care in the Swedish Obese Subjects study and in persons in the SOS reference study. The adjusted median life expectancy with surgery was 3.0 years longer than in contr...

Full description

Saved in:
Bibliographic Details
Published inNEW ENGLAND JOURNAL OF MEDICINE Vol. 383; no. 16; pp. 1535 - 1543
Main Authors Carlsson, Lena M.S, Sjöholm, Kajsa, Jacobson, Peter, Andersson-Assarsson, Johanna C, Svensson, Per-Arne, Taube, Magdalena, Carlsson, Björn, Peltonen, Markku
Format Journal Article Publication
LanguageEnglish
Published United States Massachusetts Medical Society 15.10.2020
Subjects
Online AccessGet full text

Cover

Loading…
Abstract This study compared long-term mortality and life expectancy among patients who underwent bariatric surgery or received usual obesity care in the Swedish Obese Subjects study and in persons in the SOS reference study. The adjusted median life expectancy with surgery was 3.0 years longer than in control patients but 5.5 years shorter than in the general population.
AbstractList Obesity shortens life expectancy. Bariatric surgery is known to reduce the long-term relative risk of death, but its effect on life expectancy is unclear.We used the Gompertz proportional hazards regression model to compare mortality and life expectancy among patients treated with either bariatric surgery (surgery group) or usual obesity care (control group) in the prospective, controlled Swedish Obese Subjects (SOS) study and participants in the SOS reference study (reference cohort), a random sample from the general population.In total, 2007 and 2040 patients were included in the surgery group and the control group, respectively, and 1135 participants were included in the reference cohort. At the time of the analysis (December 31, 2018), the median duration of follow-up for mortality was 24 years (interquartile range, 22 to 27) in the surgery group and 22 years (interquartile range, 21 to 27) in the control group; data on mortality were available for 99.9% of patients in the study. In the SOS reference cohort, the median duration of follow-up was 20 years (interquartile range, 19 to 21), and data on mortality were available for 100% of participants. In total, 457 patients (22.8%) in the surgery group and 539 patients (26.4%) in the control group died (hazard ratio, 0.77; 95% confidence interval [CI], 0.68 to 0.87; P<0.001). The corresponding hazard ratio was 0.70 (95% CI, 0.57 to 0.85) for death from cardiovascular disease and 0.77 (95% CI, 0.61 to 0.96) for death from cancer. The adjusted median life expectancy in the surgery group was 3.0 years (95% CI, 1.8 to 4.2) longer than in the control group but 5.5 years shorter than in the general population. The 90-day postoperative mortality was 0.2%, and 2.9% of the patients in the surgery group underwent repeat surgery.Among patients with obesity, bariatric surgery was associated with longer life expectancy than usual obesity care. Mortality remained higher in both groups than in the general population. (Funded by the Swedish Research Council and others; SOS ClinicalTrials.gov number, NCT01479452.).
Obesity shortens life expectancy. Bariatric surgery is known to reduce the long-term relative risk of death, but its effect on life expectancy is unclear. We used the Gompertz proportional hazards regression model to compare mortality and life expectancy among patients treated with either bariatric surgery (surgery group) or usual obesity care (control group) in the prospective, controlled Swedish Obese Subjects (SOS) study and participants in the SOS reference study (reference cohort), a random sample from the general population. In total, 2007 and 2040 patients were included in the surgery group and the control group, respectively, and 1135 participants were included in the reference cohort. At the time of the analysis (December 31, 2018), the median duration of follow-up for mortality was 24 years (interquartile range, 22 to 27) in the surgery group and 22 years (interquartile range, 21 to 27) in the control group; data on mortality were available for 99.9% of patients in the study. In the SOS reference cohort, the median duration of follow-up was 20 years (interquartile range, 19 to 21), and data on mortality were available for 100% of participants. In total, 457 patients (22.8%) in the surgery group and 539 patients (26.4%) in the control group died (hazard ratio, 0.77; 95% confidence interval [CI], 0.68 to 0.87; P<0.001). The corresponding hazard ratio was 0.70 (95% CI, 0.57 to 0.85) for death from cardiovascular disease and 0.77 (95% CI, 0.61 to 0.96) for death from cancer. The adjusted median life expectancy in the surgery group was 3.0 years (95% CI, 1.8 to 4.2) longer than in the control group but 5.5 years shorter than in the general population. The 90-day postoperative mortality was 0.2%, and 2.9% of the patients in the surgery group underwent repeat surgery. Among patients with obesity, bariatric surgery was associated with longer life expectancy than usual obesity care. Mortality remained higher in both groups than in the general population. (Funded by the Swedish Research Council and others; SOS ClinicalTrials.gov number, NCT01479452.).
BackgroundObesity shortens life expectancy. Bariatric surgery is known to reduce the long-term relative risk of death, but its effect on life expectancy is unclear.MethodsWe used the Gompertz proportional hazards regression model to compare mortality and life expectancy among patients treated with either bariatric surgery (surgery group) or usual obesity care (control group) in the prospective, controlled Swedish Obese Subjects (SOS) study and participants in the SOS reference study (reference cohort), a random sample from the general population.ResultsIn total, 2007 and 2040 patients were included in the surgery group and the control group, respectively, and 1135 participants were included in the reference cohort. At the time of the analysis (December 31, 2018), the median duration of follow-up for mortality was 24 years (interquartile range, 22 to 27) in the surgery group and 22 years (interquartile range, 21 to 27) in the control group; data on mortality were available for 99.9% of patients in the study. In the SOS reference cohort, the median duration of follow-up was 20 years (interquartile range, 19 to 21), and data on mortality were available for 100% of participants. In total, 457 patients (22.8%) in the surgery group and 539 patients (26.4%) in the control group died (hazard ratio, 0.77; 95% confidence interval [CI], 0.68 to 0.87; P<0.001). The corresponding hazard ratio was 0.70 (95% CI, 0.57 to 0.85) for death from cardiovascular disease and 0.77 (95% CI, 0.61 to 0.96) for death from cancer. The adjusted median life expectancy in the surgery group was 3.0 years (95% CI, 1.8 to 4.2) longer than in the control group but 5.5 years shorter than in the general population. The 90-day postoperative mortality was 0.2%, and 2.9% of the patients in the surgery group underwent repeat surgery.ConclusionsAmong patients with obesity, bariatric surgery was associated with longer life expectancy than usual obesity care. Mortality remained higher in both groups than in the general population. (Funded by the Swedish Research Council and others; SOS ClinicalTrials.gov number, NCT01479452.)
Obesity shortens life expectancy. Bariatric surgery is known to reduce the long-term relative risk of death, but its effect on life expectancy is unclear.BACKGROUNDObesity shortens life expectancy. Bariatric surgery is known to reduce the long-term relative risk of death, but its effect on life expectancy is unclear.We used the Gompertz proportional hazards regression model to compare mortality and life expectancy among patients treated with either bariatric surgery (surgery group) or usual obesity care (control group) in the prospective, controlled Swedish Obese Subjects (SOS) study and participants in the SOS reference study (reference cohort), a random sample from the general population.METHODSWe used the Gompertz proportional hazards regression model to compare mortality and life expectancy among patients treated with either bariatric surgery (surgery group) or usual obesity care (control group) in the prospective, controlled Swedish Obese Subjects (SOS) study and participants in the SOS reference study (reference cohort), a random sample from the general population.In total, 2007 and 2040 patients were included in the surgery group and the control group, respectively, and 1135 participants were included in the reference cohort. At the time of the analysis (December 31, 2018), the median duration of follow-up for mortality was 24 years (interquartile range, 22 to 27) in the surgery group and 22 years (interquartile range, 21 to 27) in the control group; data on mortality were available for 99.9% of patients in the study. In the SOS reference cohort, the median duration of follow-up was 20 years (interquartile range, 19 to 21), and data on mortality were available for 100% of participants. In total, 457 patients (22.8%) in the surgery group and 539 patients (26.4%) in the control group died (hazard ratio, 0.77; 95% confidence interval [CI], 0.68 to 0.87; P<0.001). The corresponding hazard ratio was 0.70 (95% CI, 0.57 to 0.85) for death from cardiovascular disease and 0.77 (95% CI, 0.61 to 0.96) for death from cancer. The adjusted median life expectancy in the surgery group was 3.0 years (95% CI, 1.8 to 4.2) longer than in the control group but 5.5 years shorter than in the general population. The 90-day postoperative mortality was 0.2%, and 2.9% of the patients in the surgery group underwent repeat surgery.RESULTSIn total, 2007 and 2040 patients were included in the surgery group and the control group, respectively, and 1135 participants were included in the reference cohort. At the time of the analysis (December 31, 2018), the median duration of follow-up for mortality was 24 years (interquartile range, 22 to 27) in the surgery group and 22 years (interquartile range, 21 to 27) in the control group; data on mortality were available for 99.9% of patients in the study. In the SOS reference cohort, the median duration of follow-up was 20 years (interquartile range, 19 to 21), and data on mortality were available for 100% of participants. In total, 457 patients (22.8%) in the surgery group and 539 patients (26.4%) in the control group died (hazard ratio, 0.77; 95% confidence interval [CI], 0.68 to 0.87; P<0.001). The corresponding hazard ratio was 0.70 (95% CI, 0.57 to 0.85) for death from cardiovascular disease and 0.77 (95% CI, 0.61 to 0.96) for death from cancer. The adjusted median life expectancy in the surgery group was 3.0 years (95% CI, 1.8 to 4.2) longer than in the control group but 5.5 years shorter than in the general population. The 90-day postoperative mortality was 0.2%, and 2.9% of the patients in the surgery group underwent repeat surgery.Among patients with obesity, bariatric surgery was associated with longer life expectancy than usual obesity care. Mortality remained higher in both groups than in the general population. (Funded by the Swedish Research Council and others; SOS ClinicalTrials.gov number, NCT01479452.).CONCLUSIONSAmong patients with obesity, bariatric surgery was associated with longer life expectancy than usual obesity care. Mortality remained higher in both groups than in the general population. (Funded by the Swedish Research Council and others; SOS ClinicalTrials.gov number, NCT01479452.).
This study compared long-term mortality and life expectancy among patients who underwent bariatric surgery or received usual obesity care in the Swedish Obese Subjects study and in persons in the SOS reference study. The adjusted median life expectancy with surgery was 3.0 years longer than in control patients but 5.5 years shorter than in the general population.
Author Jacobson, Peter
Andersson-Assarsson, Johanna C
Carlsson, Björn
Carlsson, Lena M.S
Taube, Magdalena
Sjöholm, Kajsa
Svensson, Per-Arne
Peltonen, Markku
Author_xml – sequence: 1
  givenname: Lena M.S
  surname: Carlsson
  fullname: Carlsson, Lena M.S
  organization: From the Institutes of Medicine (L.M.S.C., K.S., P.J., J.C.A.-A., P.-A.S., M.T., B.C.) and Health and Care Sciences (P.-A.S.), Sahlgrenska Academy at the University of Gothenburg, and Early Cardiovascular, Renal, and Metabolism (CVRM), Biopharmaceuticals Research and Development, AstraZeneca (B.C.), Gothenburg, and the Department of Neurobiology, Care Sciences and Society, Karolinska Institutet, Solna (M.P.) — both in Sweden; and the Public Health Promotion Unit, National Institute for Health and Welfare, Helsinki (M.P.)
– sequence: 2
  givenname: Kajsa
  surname: Sjöholm
  fullname: Sjöholm, Kajsa
  organization: From the Institutes of Medicine (L.M.S.C., K.S., P.J., J.C.A.-A., P.-A.S., M.T., B.C.) and Health and Care Sciences (P.-A.S.), Sahlgrenska Academy at the University of Gothenburg, and Early Cardiovascular, Renal, and Metabolism (CVRM), Biopharmaceuticals Research and Development, AstraZeneca (B.C.), Gothenburg, and the Department of Neurobiology, Care Sciences and Society, Karolinska Institutet, Solna (M.P.) — both in Sweden; and the Public Health Promotion Unit, National Institute for Health and Welfare, Helsinki (M.P.)
– sequence: 3
  givenname: Peter
  surname: Jacobson
  fullname: Jacobson, Peter
  organization: From the Institutes of Medicine (L.M.S.C., K.S., P.J., J.C.A.-A., P.-A.S., M.T., B.C.) and Health and Care Sciences (P.-A.S.), Sahlgrenska Academy at the University of Gothenburg, and Early Cardiovascular, Renal, and Metabolism (CVRM), Biopharmaceuticals Research and Development, AstraZeneca (B.C.), Gothenburg, and the Department of Neurobiology, Care Sciences and Society, Karolinska Institutet, Solna (M.P.) — both in Sweden; and the Public Health Promotion Unit, National Institute for Health and Welfare, Helsinki (M.P.)
– sequence: 4
  givenname: Johanna C
  surname: Andersson-Assarsson
  fullname: Andersson-Assarsson, Johanna C
  organization: From the Institutes of Medicine (L.M.S.C., K.S., P.J., J.C.A.-A., P.-A.S., M.T., B.C.) and Health and Care Sciences (P.-A.S.), Sahlgrenska Academy at the University of Gothenburg, and Early Cardiovascular, Renal, and Metabolism (CVRM), Biopharmaceuticals Research and Development, AstraZeneca (B.C.), Gothenburg, and the Department of Neurobiology, Care Sciences and Society, Karolinska Institutet, Solna (M.P.) — both in Sweden; and the Public Health Promotion Unit, National Institute for Health and Welfare, Helsinki (M.P.)
– sequence: 5
  givenname: Per-Arne
  surname: Svensson
  fullname: Svensson, Per-Arne
  organization: From the Institutes of Medicine (L.M.S.C., K.S., P.J., J.C.A.-A., P.-A.S., M.T., B.C.) and Health and Care Sciences (P.-A.S.), Sahlgrenska Academy at the University of Gothenburg, and Early Cardiovascular, Renal, and Metabolism (CVRM), Biopharmaceuticals Research and Development, AstraZeneca (B.C.), Gothenburg, and the Department of Neurobiology, Care Sciences and Society, Karolinska Institutet, Solna (M.P.) — both in Sweden; and the Public Health Promotion Unit, National Institute for Health and Welfare, Helsinki (M.P.)
– sequence: 6
  givenname: Magdalena
  surname: Taube
  fullname: Taube, Magdalena
  organization: From the Institutes of Medicine (L.M.S.C., K.S., P.J., J.C.A.-A., P.-A.S., M.T., B.C.) and Health and Care Sciences (P.-A.S.), Sahlgrenska Academy at the University of Gothenburg, and Early Cardiovascular, Renal, and Metabolism (CVRM), Biopharmaceuticals Research and Development, AstraZeneca (B.C.), Gothenburg, and the Department of Neurobiology, Care Sciences and Society, Karolinska Institutet, Solna (M.P.) — both in Sweden; and the Public Health Promotion Unit, National Institute for Health and Welfare, Helsinki (M.P.)
– sequence: 7
  givenname: Björn
  surname: Carlsson
  fullname: Carlsson, Björn
  organization: From the Institutes of Medicine (L.M.S.C., K.S., P.J., J.C.A.-A., P.-A.S., M.T., B.C.) and Health and Care Sciences (P.-A.S.), Sahlgrenska Academy at the University of Gothenburg, and Early Cardiovascular, Renal, and Metabolism (CVRM), Biopharmaceuticals Research and Development, AstraZeneca (B.C.), Gothenburg, and the Department of Neurobiology, Care Sciences and Society, Karolinska Institutet, Solna (M.P.) — both in Sweden; and the Public Health Promotion Unit, National Institute for Health and Welfare, Helsinki (M.P.)
– sequence: 8
  givenname: Markku
  surname: Peltonen
  fullname: Peltonen, Markku
  organization: From the Institutes of Medicine (L.M.S.C., K.S., P.J., J.C.A.-A., P.-A.S., M.T., B.C.) and Health and Care Sciences (P.-A.S.), Sahlgrenska Academy at the University of Gothenburg, and Early Cardiovascular, Renal, and Metabolism (CVRM), Biopharmaceuticals Research and Development, AstraZeneca (B.C.), Gothenburg, and the Department of Neurobiology, Care Sciences and Society, Karolinska Institutet, Solna (M.P.) — both in Sweden; and the Public Health Promotion Unit, National Institute for Health and Welfare, Helsinki (M.P.)
BackLink https://www.ncbi.nlm.nih.gov/pubmed/33053284$$D View this record in MEDLINE/PubMed
https://gup.ub.gu.se/publication/298539$$DView record from Swedish Publication Index
http://kipublications.ki.se/Default.aspx?queryparsed=id:$$DView record from Swedish Publication Index
BookMark eNp9kk1vEzEQhi1URNPCkStaCSFxWbDXn3tBKlX4DPQQOFte7zhxyO4G20vJv8chaSFIxRd7xs-8ej2eM3TSDz0g9JjgFwRz8fLz9MOnwVQYV4zV99CEcEpLxrA4QZOcVCWTNT1FZzGucF6E1Q_QKaWY00qxCfo48w6K6c8N2GR6uy2MSxCK1yZ4k4K3xXwMCwjbwvdFWkIxv4bWx2Vx1UDM0discmEs5mlstw_RfWfWER4d9nP09c30y-W7cnb19v3lxay0XMlUstoKxRQGVdVSOieJACyqhjLnrFLZNCYCc2lJhSUDQo1tXaOcBVm3Qlh6jsq9bryGzdjoTfCdCVs9GK8PqW_5BFrw_GD5X34xbnROLcYdX9WK0zrzr_Z8hjtoLfQpmPVR2fFN75d6MfzQkisslcgCzw8CYfg-Qky689HCem16GMaoK8YJVYTULKNP_0FXwxj63L7fFOFcKpKpJ387urVy848ZoHvAhiHGAE5bn0zyw86gX2uC9W5a9NG0_GnMbdWN8F38sz3fdVH3sOru4H4B1t3L-w
CitedBy_id crossref_primary_10_1161_CIRCULATIONAHA_120_051752
crossref_primary_10_1016_j_soard_2022_12_003
crossref_primary_10_1016_j_metabol_2023_155773
crossref_primary_10_1007_s11695_021_05483_x
crossref_primary_10_3390_jcm10235627
crossref_primary_10_3390_nu14122381
crossref_primary_10_1093_cvr_cvac176
crossref_primary_10_1016_j_gastre_2024_04_051
crossref_primary_10_1016_j_orcp_2023_12_001
crossref_primary_10_1111_joim_13343
crossref_primary_10_1016_j_jss_2024_10_025
crossref_primary_10_1038_s41366_024_01599_z
crossref_primary_10_1016_S2213_8587_21_00141_8
crossref_primary_10_1093_eurheartj_ehac071
crossref_primary_10_1097_IN9_0000000000000033
crossref_primary_10_1007_s13679_023_00528_x
crossref_primary_10_1007_s40619_023_01235_4
crossref_primary_10_1007_s00464_022_09387_4
crossref_primary_10_3390_jcm12051848
crossref_primary_10_1016_j_obmed_2024_100580
crossref_primary_10_3238_PersDia_2021_11_05_07
crossref_primary_10_1038_s41366_021_01028_5
crossref_primary_10_1016_j_ecl_2022_09_002
crossref_primary_10_1007_s00125_022_05861_9
crossref_primary_10_1016_j_metabol_2023_155764
crossref_primary_10_1136_bmjopen_2021_053839
crossref_primary_10_3390_jcm13010256
crossref_primary_10_1016_j_mcna_2021_06_005
crossref_primary_10_3390_nu16223926
crossref_primary_10_1016_j_asjsur_2021_12_064
crossref_primary_10_1016_j_sipas_2022_100140
crossref_primary_10_1016_S0140_6736_21_00952_1
crossref_primary_10_12688_wellcomeopenres_19498_1
crossref_primary_10_1016_S0140_6736_21_00591_2
crossref_primary_10_12688_wellcomeopenres_19498_2
crossref_primary_10_12688_wellcomeopenres_19498_3
crossref_primary_10_12688_wellcomeopenres_19498_4
crossref_primary_10_1007_s11154_023_09805_5
crossref_primary_10_1089_dia_2024_0122
crossref_primary_10_1001_jamanetworkopen_2022_6722
crossref_primary_10_1159_000538968
crossref_primary_10_12968_gasn_2020_18_9_10
crossref_primary_10_2169_naika_111_1931
crossref_primary_10_1136_gutjnl_2023_330595
crossref_primary_10_1007_s11695_023_06785_y
crossref_primary_10_1016_j_gastrohep_2023_12_008
crossref_primary_10_1016_j_clnu_2024_10_037
crossref_primary_10_1111_obr_13848
crossref_primary_10_1002_bimj_202300069
crossref_primary_10_1093_cvr_cvae016
crossref_primary_10_1159_000513068
crossref_primary_10_1097_SLA_0000000000005054
crossref_primary_10_1007_s11560_021_00502_5
crossref_primary_10_1080_14779072_2024_2363395
crossref_primary_10_1210_clinem_dgad473
crossref_primary_10_1177_10497323211040767
crossref_primary_10_1186_s12902_022_00980_1
crossref_primary_10_1016_j_eprac_2022_08_002
crossref_primary_10_1016_j_ebiom_2023_104621
crossref_primary_10_1007_s11605_023_05580_5
crossref_primary_10_1007_s11695_024_07510_z
crossref_primary_10_1177_00031348231220576
crossref_primary_10_17476_jmbs_2022_11_2_13
crossref_primary_10_1007_s00104_022_01690_z
crossref_primary_10_1007_s11695_023_06883_x
crossref_primary_10_1055_a_2075_1198
crossref_primary_10_1111_dom_14665
crossref_primary_10_1111_ans_18673
crossref_primary_10_1016_j_gastha_2023_06_005
crossref_primary_10_1016_j_soard_2021_09_003
crossref_primary_10_1089_bari_2024_0038
crossref_primary_10_1159_000533609
crossref_primary_10_1007_s11428_024_01158_0
crossref_primary_10_1007_s11883_023_01182_3
crossref_primary_10_1097_AS9_0000000000000420
crossref_primary_10_1007_s11695_021_05446_2
crossref_primary_10_1038_s41598_024_67710_6
crossref_primary_10_20945_2359_3997000000465
crossref_primary_10_1016_j_soard_2023_03_005
crossref_primary_10_1007_s11695_024_07529_2
crossref_primary_10_1038_s41598_022_23241_6
crossref_primary_10_1097_SLA_0000000000005155
crossref_primary_10_1097_SLA_0000000000006003
crossref_primary_10_58664_mustjournal_2023_09_001
crossref_primary_10_1016_j_molmet_2024_101979
crossref_primary_10_1016_j_jchirv_2020_11_004
crossref_primary_10_1111_obr_13420
crossref_primary_10_17925_EE_2023_19_1_33
crossref_primary_10_3389_fendo_2023_1215596
crossref_primary_10_1016_j_lanepe_2025_101261
crossref_primary_10_1055_s_0041_1730407
crossref_primary_10_1152_ajpendo_00327_2023
crossref_primary_10_1055_a_1657_2047
crossref_primary_10_1111_cas_15492
crossref_primary_10_1007_s11695_023_06624_0
crossref_primary_10_1016_j_neubiorev_2024_105598
crossref_primary_10_1007_s11695_022_06280_w
crossref_primary_10_1093_bjsopen_zrac145
crossref_primary_10_1001_jamanetworkopen_2021_15267
crossref_primary_10_1111_1471_0528_18032
crossref_primary_10_1038_s44324_024_00030_5
crossref_primary_10_1177_17504589241300274
crossref_primary_10_1007_s11428_021_00719_x
crossref_primary_10_1056_NEJMc2033331
crossref_primary_10_7570_jomes23078
crossref_primary_10_3389_fsurg_2022_943544
crossref_primary_10_1001_jamasurg_2022_6998
crossref_primary_10_1001_jamasurg_2022_6999
crossref_primary_10_1038_s41577_024_01103_8
crossref_primary_10_1161_CIR_0000000000001052
crossref_primary_10_1001_jamasurg_2023_6254
crossref_primary_10_17476_jmbs_2022_11_2_39
crossref_primary_10_1007_s11695_021_05626_0
crossref_primary_10_1042_CS20210506
crossref_primary_10_1111_cob_12657
crossref_primary_10_3390_cancers15020485
crossref_primary_10_1007_s13679_021_00448_8
crossref_primary_10_1016_j_gie_2023_10_033
crossref_primary_10_1007_s40619_022_01150_0
crossref_primary_10_1016_j_jacc_2024_07_012
crossref_primary_10_1016_j_soard_2024_11_016
crossref_primary_10_1186_s12902_021_00723_8
crossref_primary_10_1016_j_mayocp_2023_11_008
crossref_primary_10_1093_milmed_usab406
crossref_primary_10_1007_s00423_024_03348_2
crossref_primary_10_1016_j_numecd_2021_05_023
crossref_primary_10_1371_journal_pone_0298402
crossref_primary_10_1007_s00595_024_02925_8
crossref_primary_10_1038_s41467_022_35553_2
crossref_primary_10_1161_JAHA_123_031665
crossref_primary_10_3389_fnins_2022_937663
crossref_primary_10_1016_j_soard_2021_10_012
crossref_primary_10_1016_j_jviscsurg_2020_12_002
crossref_primary_10_3390_cancers14215402
crossref_primary_10_1002_oby_23646
crossref_primary_10_1038_s41366_021_00986_0
crossref_primary_10_1016_j_explore_2021_11_006
crossref_primary_10_1097_MCG_0000000000001916
crossref_primary_10_1016_j_foodhyd_2023_108521
crossref_primary_10_3389_fendo_2023_1218880
crossref_primary_10_1001_jamanetworkopen_2023_53141
crossref_primary_10_1038_s42255_022_00674_x
crossref_primary_10_1016_j_soard_2022_12_038
crossref_primary_10_3390_jcm10163685
crossref_primary_10_1002_14651858_CD011740_pub2
crossref_primary_10_1007_s11695_021_05763_6
crossref_primary_10_1089_bari_2023_0012
crossref_primary_10_1007_s13679_021_00450_0
crossref_primary_10_1007_s11695_023_06585_4
crossref_primary_10_20945_2359_3997000000550
crossref_primary_10_1038_s41572_024_00511_3
crossref_primary_10_1016_j_clnu_2023_01_015
crossref_primary_10_1024_1661_8157_a003615
crossref_primary_10_3390_cimb45090455
crossref_primary_10_1016_j_soard_2022_05_007
crossref_primary_10_3389_fphar_2023_1133415
crossref_primary_10_1016_S2666_7568_23_00141_1
crossref_primary_10_1007_s11892_023_01498_z
crossref_primary_10_1089_met_2022_0101
crossref_primary_10_1016_S2589_7500_23_00135_8
crossref_primary_10_1002_ehf2_14641
crossref_primary_10_1093_eurjpc_zwad280
crossref_primary_10_1590_0100_6991e_20223335_en
crossref_primary_10_1007_s11695_024_07500_1
crossref_primary_10_3390_pharmaceutics13111873
crossref_primary_10_1097_MCG_0000000000001662
crossref_primary_10_1007_s11695_022_05986_1
crossref_primary_10_1001_jamasurg_2024_1169
crossref_primary_10_1002_oby_23462
crossref_primary_10_1111_dom_16219
crossref_primary_10_1159_000516991
crossref_primary_10_7759_cureus_22999
crossref_primary_10_1055_a_1313_5112
crossref_primary_10_1080_17446651_2022_2110865
crossref_primary_10_1016_j_amjcard_2020_12_049
crossref_primary_10_1016_j_pharmthera_2021_107923
crossref_primary_10_1055_a_1324_6140
crossref_primary_10_3389_fendo_2022_921353
crossref_primary_10_1007_s11695_024_07196_3
crossref_primary_10_1007_s13679_023_00508_1
crossref_primary_10_1007_s11695_022_06122_9
crossref_primary_10_3322_caac_21694
crossref_primary_10_1016_j_cpsurg_2024_101549
crossref_primary_10_3390_jcm11051340
crossref_primary_10_1002_ardp_202400966
crossref_primary_10_3389_fendo_2022_934680
crossref_primary_10_1007_s00464_025_11606_7
crossref_primary_10_1056_NEJMra2032804
crossref_primary_10_1007_s11695_023_06963_y
crossref_primary_10_1093_eurheartj_ehad664
crossref_primary_10_1016_j_soard_2023_01_029
crossref_primary_10_1016_S2213_8587_22_00317_5
crossref_primary_10_1093_eurjpc_zwae279
crossref_primary_10_1055_a_2029_5283
crossref_primary_10_1111_cob_12695
crossref_primary_10_1007_s11695_023_06959_8
crossref_primary_10_1016_j_isci_2021_103421
crossref_primary_10_1016_j_cnur_2021_07_008
crossref_primary_10_1016_j_numecd_2023_02_008
crossref_primary_10_1590_0100_6991e_20223335
crossref_primary_10_1001_jamanetworkopen_2024_14340
crossref_primary_10_1016_j_joca_2022_11_015
crossref_primary_10_1007_s11695_024_07547_0
crossref_primary_10_7759_cureus_34723
crossref_primary_10_1249_JES_0000000000000253
crossref_primary_10_1007_s00104_024_02149_z
crossref_primary_10_1007_s11695_021_05732_z
crossref_primary_10_3390_ijms23063339
crossref_primary_10_3390_cancers13133183
crossref_primary_10_1038_s41574_020_00440_7
crossref_primary_10_1016_j_giec_2024_03_004
crossref_primary_10_1016_j_ecl_2023_01_002
crossref_primary_10_5812_amh_148223
crossref_primary_10_1089_lap_2020_0910
crossref_primary_10_1093_ckj_sfae291
crossref_primary_10_1007_s10620_022_07519_3
crossref_primary_10_2169_naika_110_449
crossref_primary_10_1016_j_ijscr_2023_108458
crossref_primary_10_3390_medicina60081221
crossref_primary_10_1007_s11695_023_06564_9
crossref_primary_10_1007_s13304_025_02097_1
crossref_primary_10_1007_s13340_021_00551_0
crossref_primary_10_1016_j_arr_2025_102727
crossref_primary_10_1002_oby_23314
crossref_primary_10_1007_s11695_021_05606_4
crossref_primary_10_1055_a_1970_3664
crossref_primary_10_15252_emmm_202114742
crossref_primary_10_1001_jamasurg_2023_0252
crossref_primary_10_1016_j_pharmthera_2023_108549
crossref_primary_10_1016_j_soard_2021_05_021
crossref_primary_10_1007_s15034_021_3752_7
crossref_primary_10_3390_nu17010189
crossref_primary_10_1038_s41366_023_01332_2
crossref_primary_10_1007_s11886_021_01515_1
crossref_primary_10_1530_EC_21_0338
crossref_primary_10_1038_s41573_021_00337_8
crossref_primary_10_17476_jmbs_2024_13_1_8
crossref_primary_10_1111_dom_14992
crossref_primary_10_1136_bmjopen_2021_053242
crossref_primary_10_1016_j_soard_2023_05_015
crossref_primary_10_1007_s11695_020_05213_9
crossref_primary_10_3390_cancers16193296
crossref_primary_10_1111_ans_19378
crossref_primary_10_1007_s11695_021_05368_z
crossref_primary_10_1111_cob_12704
crossref_primary_10_1111_dom_16010
crossref_primary_10_1089_lap_2021_0847
crossref_primary_10_1016_j_metabol_2022_155341
crossref_primary_10_1016_j_orcp_2021_11_004
crossref_primary_10_1007_s11695_021_05308_x
crossref_primary_10_1016_j_jep_2024_118814
crossref_primary_10_1007_s11695_023_06565_8
crossref_primary_10_1007_s13300_021_01032_y
crossref_primary_10_3390_nu13093150
crossref_primary_10_14797_mdcvj_1513
crossref_primary_10_1038_s41366_024_01529_z
crossref_primary_10_1007_s00404_023_07367_0
crossref_primary_10_1097_JS9_0000000000000066
crossref_primary_10_1007_s11695_022_06150_5
crossref_primary_10_1055_a_2116_9397
crossref_primary_10_1089_dia_2023_0036
crossref_primary_10_1093_eurheartj_ehad192
crossref_primary_10_1007_s11695_025_07716_9
crossref_primary_10_1001_jamanetworkopen_2022_47226
crossref_primary_10_1002_oby_24103
crossref_primary_10_3390_jcm10040674
crossref_primary_10_1055_a_1652_4605
crossref_primary_10_1111_dom_16263
crossref_primary_10_1093_eurheartj_ehae508
crossref_primary_10_1177_26345161241245034
crossref_primary_10_1001_jamasurg_2021_6496
crossref_primary_10_1007_s11695_021_05795_y
crossref_primary_10_1007_s11695_023_06555_w
crossref_primary_10_1007_s11695_023_06570_x
crossref_primary_10_1016_j_molmet_2021_101237
crossref_primary_10_3748_wjg_v27_i19_2281
crossref_primary_10_1002_oby_23800
crossref_primary_10_1016_j_soard_2022_07_003
crossref_primary_10_3389_fendo_2023_1072540
crossref_primary_10_2337_dc21_2441
crossref_primary_10_3389_fnut_2024_1509994
crossref_primary_10_1016_j_molmet_2020_101153
crossref_primary_10_1210_clinem_dgab091
crossref_primary_10_1002_oby_23922
crossref_primary_10_1007_s00280_024_04640_0
crossref_primary_10_7570_jomes23008
crossref_primary_10_1001_jamanetworkopen_2021_48317
crossref_primary_10_1007_s11695_024_07576_9
crossref_primary_10_1038_s42255_022_00677_8
crossref_primary_10_2337_dc21_1335
crossref_primary_10_1016_j_amjmed_2022_03_017
crossref_primary_10_1177_00031348221109497
crossref_primary_10_1016_j_mayocp_2024_05_022
crossref_primary_10_1007_s11845_023_03482_8
crossref_primary_10_3389_fcvm_2021_721956
crossref_primary_10_1001_jamasurg_2024_2162
crossref_primary_10_1016_j_soard_2021_06_020
crossref_primary_10_1097_JS9_0000000000001807
crossref_primary_10_1001_jamainternmed_2023_3798
crossref_primary_10_1038_s41366_021_00910_6
crossref_primary_10_1016_j_ygyno_2021_02_007
crossref_primary_10_1002_cncr_34721
crossref_primary_10_1016_j_heliyon_2024_e38678
Cites_doi 10.1016/S2213-8587(18)30288-2
10.1007/s10654-017-0316-1
10.1038/s41366-018-0097-y
10.1038/ncpendmet0966
10.1056/NEJM199005243222101
10.1002/oby.20397
10.1056/NEJMoa1600869
10.1002/j.1550-8528.1994.tb00087.x
10.1097/SLA.0000000000003742
10.1053/j.gastro.2019.03.048
10.1016/S0140-6736(09)60318-4
10.1136/bmj.g3961
10.1080/01621459.1999.10474144
10.1016/S2213-8587(17)30437-0
10.1038/s41366-019-0397-x
10.1001/jama.289.2.187
10.21037/atm.2018.03.16
10.1161/CIRCRESAHA.116.307591
10.1111/dom.12922
10.1007/s11695-018-3493-4
10.1007/s11695-014-1237-7
10.1056/NEJMoa066603
10.1016/S0140-6736(15)00075-6
10.1038/sj.ijo.0802732
10.1056/NEJM199808063390606
10.1056/NEJMoa066254
10.1111/joim.12012
10.1016/S0195-668X(03)00114-3
ContentType Journal Article
Publication
Copyright Copyright © 2020 Massachusetts Medical Society. All rights reserved.
Copyright © 2020 Massachusetts Medical Society.
Copyright_xml – notice: Copyright © 2020 Massachusetts Medical Society. All rights reserved.
– notice: Copyright © 2020 Massachusetts Medical Society.
DBID AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
7RV
7X7
7XB
8AO
8C1
8FE
8FH
8FI
ABUWG
AFKRA
AN0
AZQEC
BBNVY
BEC
BENPR
BHPHI
CCPQU
DWQXO
FYUFA
GHDGH
GNUQQ
GUQSH
HCIFZ
K0Y
LK8
M0R
M0T
M1P
M2M
M2O
M2P
M7P
MBDVC
NAPCQ
PHGZM
PHGZT
PJZUB
PKEHL
PPXIY
PQEST
PQGLB
PQQKQ
PQUKI
PRINS
PSYQQ
Q9U
7X8
5PM
ADTPV
AOWAS
F1U
BZJLE
DOI 10.1056/NEJMoa2002449
DatabaseName CrossRef
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
Nursing & Allied Health Database
Health & Medical Collection
ProQuest Central (purchase pre-March 2016)
ProQuest Pharma Collection
ProQuest Public Health Database (NC LIVE)
ProQuest SciTech Collection
ProQuest Natural Science Collection
Hospital Premium Collection
ProQuest Central (Alumni)
ProQuest Central UK/Ireland
British Nursing Database (Proquest)
ProQuest Central Essentials
Biological Science Database
ProQuest eLibrary (NC LIVE)
ProQuest Central
Natural Science Collection
ProQuest One Community College
ProQuest Central Korea
Health Research Premium Collection
Health Research Premium Collection (Alumni)
ProQuest Central Student
ProQuest Research Library
SciTech Premium Collection
New England Journal of Medicine
ProQuest Biological Science Collection
Consumer Health Database
Healthcare Administration Database
Medical Database
ProQuest Psychology Database (NC LIVE)
Research Library
Science Database
Biological Science Database
Research Library (Corporate)
Nursing & Allied Health Premium
ProQuest Central Premium
ProQuest One Academic
ProQuest Health & Medical Research Collection
ProQuest One Academic Middle East (New)
ProQuest One Health & Nursing
ProQuest One Academic Eastern Edition (DO NOT USE)
ProQuest One Applied & Life Sciences
ProQuest One Academic
ProQuest One Academic UKI Edition
ProQuest Central China
ProQuest One Psychology
ProQuest Central Basic
MEDLINE - Academic
PubMed Central (Full Participant titles)
SwePub
SwePub Articles
SWEPUB Göteborgs universitet
SwePub Other
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
ProQuest One Psychology
Research Library Prep
ProQuest Central Student
ProQuest One Academic Middle East (New)
ProQuest Central Essentials
elibrary
ProQuest Central (Alumni Edition)
SciTech Premium Collection
ProQuest One Community College
ProQuest One Health & Nursing
New England Journal of Medicine
ProQuest Natural Science Collection
ProQuest Pharma Collection
ProQuest Central China
ProQuest Central
ProQuest One Applied & Life Sciences
ProQuest Health & Medical Research Collection
Health Research Premium Collection
Natural Science Collection
ProQuest Central Korea
Health & Medical Research Collection
Biological Science Collection
ProQuest Research Library
ProQuest Central (New)
ProQuest Public Health
ProQuest Biological Science Collection
ProQuest Central Basic
ProQuest Science Journals
ProQuest Family Health
ProQuest One Academic Eastern Edition
British Nursing Index with Full Text
ProQuest Health Management
ProQuest Nursing & Allied Health Source
ProQuest Hospital Collection
Health Research Premium Collection (Alumni)
Biological Science Database
ProQuest SciTech Collection
Nursing & Allied Health Premium
ProQuest Health & Medical Complete
ProQuest Medical Library
ProQuest Psychology Journals
ProQuest One Academic UKI Edition
ProQuest One Academic
ProQuest One Academic (New)
MEDLINE - Academic
DatabaseTitleList
MEDLINE
ProQuest One Psychology
MEDLINE - Academic

Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
– sequence: 3
  dbid: BENPR
  name: ProQuest Central
  url: https://www.proquest.com/central
  sourceTypes: Aggregation Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
Education
EISSN 1533-4406
EndPage 1543
ExternalDocumentID oai_swepub_ki_se_650017
oai_gup_ub_gu_se_298539
PMC7580786
33053284
10_1056_NEJMoa2002449
NJ202010153831608
Genre Original Article
Comparative Study
Research Support, Non-U.S. Gov't
Journal Article
Research Support, N.I.H., Extramural
GeographicLocations Sweden
GeographicLocations_xml – name: Sweden
GrantInformation_xml – fundername: United States
  grantid: 20180410
– fundername: United States
  grantid: ALFGBG-717881 and ALFGBG-717891
– fundername: NIDDK NIH HHS
  grantid: R01 DK105948
– fundername: United States
  grantid: 2019-417
– fundername: United States
  grantid: 2017-01707
– fundername: Novo Nordisk Fonden
  grantid: NNF 19OC0057184
– fundername: United States
  grantid: R01DK105948
GroupedDBID -
0R
0WA
123
186
1VV
29N
2KS
2WC
34G
39C
4
4.4
53G
55
5RE
7FN
7RV
7X7
85S
8AO
8C1
8FE
8FH
8FI
AACLI
AAEJM
AAIKC
AALRV
AAPBV
AAQQT
AARDX
AAWTL
ABACO
ABEHJ
ABFLS
ABIVO
ABOCM
ABPPZ
ABPTK
ABQIJ
ABUWG
ABWJO
ACGFS
ACGOD
ACJLH
ACNCT
ACPRK
ACRZS
ADBBV
ADBIT
ADCBC
AENEX
AETEA
AFFNX
AFHKK
AFKRA
AGFXO
AGNAY
AHMBA
AJJEV
AJVPN
ALMA_UNASSIGNED_HOLDINGS
AN0
AQUVI
AZQEC
BBAFP
BBNVY
BCU
BENPR
BES
BHPHI
BKEYQ
BKNYI
BLC
BNQBC
BPHCQ
BVXVI
C45
CJ0
CO
CS3
DCD
DU5
DWQXO
DZ
EBS
ET
EX3
F5P
FD8
FM.
FYUFA
GJ
GNUQQ
GUQSH
HCIFZ
HZ
I4R
IH2
K-O
KM
KOO
L7B
LK8
M0R
M0T
M1P
M2M
M2O
M2P
M7P
MVM
N9A
NAPCQ
NEJ
O9-
OK1
OMK
OVD
P-O
P-S
P2P
PADUT
PCD
PQEST
PQQKQ
PQUKI
PRINS
PROAC
PSQYO
QJJ
RHI
RWL
RXW
S10
S6N
SJFOW
SJN
TAE
TAF
TEORI
TN5
TUQ
TWZ
UCV
UKR
UMD
VQA
W2G
WH7
WOQ
WOW
X
X7M
XJT
XYN
XZL
YCJ
YNT
YRY
YZZ
ZA5
ZHY
ZR0
---
-DZ
-ET
-~X
.-4
.55
.CO
.GJ
0R~
36B
AAMNW
AAYXX
ABBLC
ABCQX
ABDQB
ABJNI
ACKOT
ACPFK
ADRHT
ADUKH
AERZD
AFOSN
AGHSJ
ALIPV
BYPQX
CCPQU
CITATION
H13
HF~
HMCUK
HZ~
N4W
PHGZM
PHGZT
PSYQQ
UKHRP
YFH
YR2
YR5
YYP
ZCA
ZVN
~KM
CGR
CUY
CVF
ECM
EIF
NPM
R.3
UIG
VXZ
YIF
YIN
Z5M
7XB
BEC
K0Y
MBDVC
PJZUB
PKEHL
PPXIY
PQGLB
Q9U
7X8
5PM
1CY
1KJ
3O-
41~
6TJ
8WZ
9M8
A6W
AAQOH
AAUTI
ABDPE
ABEFU
ACPVT
ACTDY
ADTPV
ADXHL
AFFDN
AJUXI
AOWAS
D0S
EJD
F1U
FA8
J5H
LPU
MQT
NHB
OHT
QZG
SKT
UBX
UQL
WHG
XOL
YHZ
YQI
YQJ
YYQ
ZGI
ZKB
ZXP
BZJLE
PUEGO
ID FETCH-LOGICAL-c587t-49c68480e82977ff716e062b34ffc88002016057c12074e13acdfb8fce79d66c3
IEDL.DBID 7X7
ISSN 0028-4793
1533-4406
IngestDate Mon Aug 25 03:24:22 EDT 2025
Thu Aug 21 06:42:44 EDT 2025
Thu Aug 21 14:02:35 EDT 2025
Fri Jul 11 09:19:23 EDT 2025
Sat Aug 23 13:02:28 EDT 2025
Wed Feb 19 02:27:53 EST 2025
Tue Jul 01 01:43:31 EDT 2025
Thu Apr 24 22:56:56 EDT 2025
Tue Dec 21 14:38:53 EST 2021
IsDoiOpenAccess false
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 16
Language English
License http://www.nejmgroup.org/legal/terms-of-use.htm
Copyright © 2020 Massachusetts Medical Society.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c587t-49c68480e82977ff716e062b34ffc88002016057c12074e13acdfb8fce79d66c3
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
ObjectType-Article-2
ObjectType-Feature-1
content type line 23
OpenAccessLink https://www.nejm.org/doi/pdf/10.1056/NEJMoa2002449?articleTools=true
PMID 33053284
PQID 2451155781
PQPubID 40644
PageCount 9
ParticipantIDs swepub_primary_oai_swepub_ki_se_650017
swepub_primary_oai_gup_ub_gu_se_298539
pubmedcentral_primary_oai_pubmedcentral_nih_gov_7580786
proquest_miscellaneous_2451381194
proquest_journals_2451155781
pubmed_primary_33053284
crossref_citationtrail_10_1056_NEJMoa2002449
crossref_primary_10_1056_NEJMoa2002449
mms_nejm_10_1056_NEJMoa2002449
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 2020-10-15
PublicationDateYYYYMMDD 2020-10-15
PublicationDate_xml – month: 10
  year: 2020
  text: 2020-10-15
  day: 15
PublicationDecade 2020
PublicationPlace United States
PublicationPlace_xml – name: United States
– name: Boston
PublicationTitle NEW ENGLAND JOURNAL OF MEDICINE
PublicationTitleAlternate N Engl J Med
PublicationYear 2020
Publisher Massachusetts Medical Society
Publisher_xml – name: Massachusetts Medical Society
References Schauer, PR, Bhatt, DL, Kirwan, JP (r026) 2017; 376
Wolfe, BM, Kvach, E, Eckel, RH (r024) 2016; 118
Kanji, S, Wong, E, Akioyamen, L, Melamed, O, Taylor, VH (r018) 2019; 43
Carlsson, LMS, Sjöholm, K, Ahlin, S (r023) 2019; 43
Fine, JP, Gray, RJ (r013) 1999; 94
Bhaskaran, K, Dos-Santos-Silva, I, Leon, DA, Douglas, IJ, Smeeth, L (r003) 2018; 6
Westerveld, D, Yang, D (r008) 2016; 2016
(r001) 2009; 373
Cardoso, L, Rodrigues, D, Gomes, L, Carrilho, F (r006) 2017; 19
Konttinen, H, Sjöholm, K, Jacobson, P, Svensson, P-A, Carlsson, LMS, Peltonen, M (r022)
Svensson, PA, Anveden, Å, Romeo, S (r020) 2013; 21
Neovius, M, Bruze, G, Jacobson, P (r021) 2018; 6
Farooqi, IS, O’Rahilly, S (r027) 2008; 4
Adams, TD, Gress, RE, Smith, SC (r019) 2007; 357
Conroy, RM, Pyörälä, K, Fitzgerald, AP (r014) 2003; 24
Arterburn, DE, Courcoulas, AP (r009) 2014; 349
Mingrone, G, Panunzi, S, De Gaetano, A (r025) 2015; 386
Fontaine, KR, Redden, DT, Wang, C, Westfall, AO, Allison, DB (r002) 2003; 289
Sjöström, L (r004) 2013; 273
Brantley, PJ, Waldo, K, Matthews-Ewald, MR (r010) 2014; 24
Bouchard, C, Tremblay, A, Després, JP (r028) 1990; 322
Bouchard, C, Tremblay, A, Després, JP (r029) 1994; 2
Larsson, I, Bertéus Forslund, H, Lindroos, AK (r012) 2004; 28
Wright, JC, Weinstein, MC (r015) 1998; 339
Brooke, HL, Talbäck, M, Hörnblad, J (r011) 2017; 32
Azam, H, Shahrestani, S, Phan, K (r017) 2018; 6
Castaneda, D, Popov, VB, Wander, P, Thompson, CC (r016) 2019; 29
Kauppila, JH, Tao, W, Santoni, G (r007) 2019; 157
Sjöström, L, Narbro, K, Sjöström, CD (r005) 2007; 357
e_1_3_5_28_2
e_1_3_5_27_2
e_1_3_5_26_2
e_1_3_5_25_2
e_1_3_5_24_2
e_1_3_5_23_2
e_1_3_5_22_2
e_1_3_5_21_2
e_1_3_5_29_2
e_1_3_5_2_2
e_1_3_5_8_2
e_1_3_5_20_2
e_1_3_5_7_2
e_1_3_5_4_2
e_1_3_5_3_2
e_1_3_5_6_2
e_1_3_5_5_2
e_1_3_5_17_2
e_1_3_5_16_2
e_1_3_5_15_2
e_1_3_5_14_2
e_1_3_5_12_2
e_1_3_5_13_2
e_1_3_5_10_2
e_1_3_5_11_2
e_1_3_5_19_2
e_1_3_5_18_2
Westerveld D (e_1_3_5_9_2) 2016; 2016
e_1_3_5_30_2
33406343 - N Engl J Med. 2021 Jan 7;384(1):88
33406342 - N Engl J Med. 2021 Jan 7;384(1):88
33144688 - Nat Rev Endocrinol. 2021 Jan;17(1):4-5
References_xml – volume: 28
  start-page: 1317
  year: 2004
  end-page: 1324
  ident: r012
  article-title: Body composition in the SOS (Swedish Obese Subjects) reference study.
  publication-title: Int J Obes Relat Metab Disord
– volume: 273
  start-page: 219
  year: 2013
  end-page: 234
  ident: r004
  article-title: Review of the key results from the Swedish Obese Subjects (SOS) trial — a prospective controlled intervention study of bariatric surgery.
  publication-title: J Intern Med
– volume: 357
  start-page: 753
  year: 2007
  end-page: 761
  ident: r019
  article-title: Long-term mortality after gastric bypass surgery.
  publication-title: N Engl J Med
– volume: 19
  start-page: 1223
  year: 2017
  end-page: 1232
  ident: r006
  article-title: Short- and long-term mortality after bariatric surgery: a systematic review and meta-analysis.
  publication-title: Diabetes Obes Metab
– volume: 24
  start-page: 987
  year: 2003
  end-page: 1003
  ident: r014
  article-title: Estimation of ten-year risk of fatal cardiovascular disease in Europe: the SCORE project.
  publication-title: Eur Heart J
– volume: 6
  start-page: 197
  year: 2018
  end-page: 207
  ident: r021
  article-title: Risk of suicide and non-fatal self-harm after bariatric surgery: results from two matched cohort studies.
  publication-title: Lancet Diabetes Endocrinol
– volume: 24
  start-page: 961
  year: 2014
  end-page: 964
  ident: r010
  article-title: Why patients seek bariatric surgery: does insurance coverage matter?
  publication-title: Obes Surg
– volume: 32
  start-page: 765
  year: 2017
  end-page: 773
  ident: r011
  article-title: The Swedish cause of death register.
  publication-title: Eur J Epidemiol
– volume: 29
  start-page: 322
  year: 2019
  end-page: 333
  ident: r016
  article-title: Risk of suicide and self-harm is increased after bariatric surgery — a systematic review and meta-analysis.
  publication-title: Obes Surg
– volume: 4
  start-page: 569
  year: 2008
  end-page: 577
  ident: r027
  article-title: Mutations in ligands and receptors of the leptin-melanocortin pathway that lead to obesity.
  publication-title: Nat Clin Pract Endocrinol Metab
– volume: 43
  start-page: 1659
  year: 2019
  end-page: 1674
  ident: r018
  article-title: Exploring pre-surgery and post-surgery substance use disorder and alcohol use disorder in bariatric surgery: a qualitative scoping review.
  publication-title: Int J Obes (Lond)
– volume: 21
  start-page: 2444
  year: 2013
  end-page: 2451
  ident: r020
  article-title: Alcohol consumption and alcohol problems after bariatric surgery in the Swedish Obese Subjects study.
  publication-title: Obesity (Silver Spring)
– volume: 118
  start-page: 1844
  year: 2016
  end-page: 1855
  ident: r024
  article-title: Treatment of obesity: weight loss and bariatric surgery.
  publication-title: Circ Res
– volume: 339
  start-page: 380
  year: 1998
  end-page: 386
  ident: r015
  article-title: Gains in life expectancy from medical interventions — standardizing data on outcomes.
  publication-title: N Engl J Med
– volume: 6
  start-page: 148
  year: 2018
  end-page: 148
  ident: r017
  article-title: Alcohol use disorders before and after bariatric surgery: a systematic review and meta-analysis.
  publication-title: Ann Transl Med
– ident: r022
  article-title: Prediction of suicide and nonfatal self-harm after bariatric surgery: a risk score based on sociodemographic factors, lifestyle behavior, and mental health: a nonrandomized controlled trial.
  publication-title: Ann Surg
– volume: 2016
  start-page: 8616581
  year: 2016
  end-page: 8616581
  ident: r008
  article-title: Through thick and thin: identifying barriers to bariatric surgery, weight loss maintenance, and tailoring obesity treatment for the future.
  publication-title: Surg Res Pract
– volume: 322
  start-page: 1477
  year: 1990
  end-page: 1482
  ident: r028
  article-title: The response to long-term overfeeding in identical twins.
  publication-title: N Engl J Med
– volume: 94
  start-page: 496
  year: 1999
  end-page: 509
  ident: r013
  article-title: A proportional hazards model for the subdistribution of a competing risk.
  publication-title: J Am Stat Assoc
– volume: 43
  start-page: 933
  year: 2019
  end-page: 937
  ident: r023
  article-title: Long-term incidence of serious fall-related injuries after bariatric surgery in Swedish obese subjects.
  publication-title: Int J Obes (Lond)
– volume: 289
  start-page: 187
  year: 2003
  end-page: 193
  ident: r002
  article-title: Years of life lost due to obesity.
  publication-title: JAMA
– volume: 2
  start-page: 400
  year: 1994
  end-page: 410
  ident: r029
  article-title: The response to exercise with constant energy intake in identical twins.
  publication-title: Obes Res
– volume: 6
  start-page: 944
  year: 2018
  end-page: 953
  ident: r003
  article-title: Association of BMI with overall and cause-specific mortality: a population-based cohort study of 3·6 million adults in the UK.
  publication-title: Lancet Diabetes Endocrinol
– volume: 376
  start-page: 641
  year: 2017
  end-page: 651
  ident: r026
  article-title: Bariatric surgery versus intensive medical therapy for diabetes — 5-year outcomes.
  publication-title: N Engl J Med
– volume: 157
  start-page: 119
  issue: 1
  year: 2019
  end-page: 127.e1
  ident: r007
  article-title: Effects of obesity surgery on overall and disease-specific mortality in a 5-country population-based study.
  publication-title: Gastroenterology
– volume: 349
  start-page: g3961
  year: 2014
  end-page: g3961
  ident: r009
  article-title: Bariatric surgery for obesity and metabolic conditions in adults.
  publication-title: BMJ
– volume: 373
  start-page: 1083
  year: 2009
  end-page: 1096
  ident: r001
  article-title: Body-mass index and cause-specific mortality in 900 000 adults: collaborative analyses of 57 prospective studies.
  publication-title: Lancet ;Prospective Studies Collaboration
– volume: 386
  start-page: 964
  year: 2015
  end-page: 973
  ident: r025
  article-title: Bariatric-metabolic surgery versus conventional medical treatment in obese patients with type 2 diabetes: 5 year follow-up of an open-label, single-centre, randomised controlled trial.
  publication-title: Lancet
– volume: 357
  start-page: 741
  year: 2007
  end-page: 752
  ident: r005
  article-title: Effects of bariatric surgery on mortality in Swedish obese subjects.
  publication-title: N Engl J Med
– ident: e_1_3_5_4_2
  doi: 10.1016/S2213-8587(18)30288-2
– ident: e_1_3_5_12_2
  doi: 10.1007/s10654-017-0316-1
– ident: e_1_3_5_24_2
  doi: 10.1038/s41366-018-0097-y
– ident: e_1_3_5_28_2
  doi: 10.1038/ncpendmet0966
– ident: e_1_3_5_29_2
  doi: 10.1056/NEJM199005243222101
– ident: e_1_3_5_21_2
  doi: 10.1002/oby.20397
– volume: 2016
  start-page: 8616581
  year: 2016
  ident: e_1_3_5_9_2
  article-title: Through thick and thin: identifying barriers to bariatric surgery, weight loss maintenance, and tailoring obesity treatment for the future.
  publication-title: Surg Res Pract
– ident: e_1_3_5_27_2
  doi: 10.1056/NEJMoa1600869
– ident: e_1_3_5_30_2
  doi: 10.1002/j.1550-8528.1994.tb00087.x
– ident: e_1_3_5_23_2
  doi: 10.1097/SLA.0000000000003742
– ident: e_1_3_5_8_2
  doi: 10.1053/j.gastro.2019.03.048
– ident: e_1_3_5_2_2
  doi: 10.1016/S0140-6736(09)60318-4
– ident: e_1_3_5_10_2
  doi: 10.1136/bmj.g3961
– ident: e_1_3_5_14_2
  doi: 10.1080/01621459.1999.10474144
– ident: e_1_3_5_22_2
  doi: 10.1016/S2213-8587(17)30437-0
– ident: e_1_3_5_19_2
  doi: 10.1038/s41366-019-0397-x
– ident: e_1_3_5_3_2
  doi: 10.1001/jama.289.2.187
– ident: e_1_3_5_18_2
  doi: 10.21037/atm.2018.03.16
– ident: e_1_3_5_25_2
  doi: 10.1161/CIRCRESAHA.116.307591
– ident: e_1_3_5_7_2
  doi: 10.1111/dom.12922
– ident: e_1_3_5_17_2
  doi: 10.1007/s11695-018-3493-4
– ident: e_1_3_5_11_2
  doi: 10.1007/s11695-014-1237-7
– ident: e_1_3_5_20_2
  doi: 10.1056/NEJMoa066603
– ident: e_1_3_5_26_2
  doi: 10.1016/S0140-6736(15)00075-6
– ident: e_1_3_5_13_2
  doi: 10.1038/sj.ijo.0802732
– ident: e_1_3_5_16_2
  doi: 10.1056/NEJM199808063390606
– ident: e_1_3_5_6_2
  doi: 10.1056/NEJMoa066254
– ident: e_1_3_5_5_2
  doi: 10.1111/joim.12012
– ident: e_1_3_5_15_2
  doi: 10.1016/S0195-668X(03)00114-3
– reference: 33144688 - Nat Rev Endocrinol. 2021 Jan;17(1):4-5
– reference: 33406343 - N Engl J Med. 2021 Jan 7;384(1):88
– reference: 33406342 - N Engl J Med. 2021 Jan 7;384(1):88
SSID ssj0000149
Score 2.700744
Snippet This study compared long-term mortality and life expectancy among patients who underwent bariatric surgery or received usual obesity care in the Swedish Obese...
Obesity shortens life expectancy. Bariatric surgery is known to reduce the long-term relative risk of death, but its effect on life expectancy is unclear. We...
BackgroundObesity shortens life expectancy. Bariatric surgery is known to reduce the long-term relative risk of death, but its effect on life expectancy is...
Obesity shortens life expectancy. Bariatric surgery is known to reduce the long-term relative risk of death, but its effect on life expectancy is...
Obesity shortens life expectancy. Bariatric surgery is known to reduce the long-term relative risk of death, but its effect on life expectancy is unclear.We...
SourceID swepub
pubmedcentral
proquest
pubmed
crossref
mms
SourceType Open Access Repository
Aggregation Database
Index Database
Enrichment Source
Publisher
StartPage 1535
SubjectTerms Adult
Age
Bariatric Surgery
Bariatric Surgery - mortality
Cardiovascular disease
Cardiovascular diseases
Case-Control Studies
Confidence intervals
Death
Diabetes
Education
epidemiology
Fasting
Female
Gastrointestinal surgery
Glucose
Humans
Hypertension
Intervention
Kirurgi
Life Expectancy
Life span
Longevity
Male
Middle Aged
Mortality
Obesity
Obesity - mortality
Obesity - surgery
Obesity - therapy
Population
Proportional Hazards Models
Prospective Studies
Reoperation
Surgery
Sweden
Sweden - epidemiology
therapy
Weight control
Title Life Expectancy after Bariatric Surgery in the Swedish Obese Subjects Study
URI https://nejm.org/doi/full/10.1056/NEJMoa2002449
https://www.ncbi.nlm.nih.gov/pubmed/33053284
https://www.proquest.com/docview/2451155781
https://www.proquest.com/docview/2451381194
https://pubmed.ncbi.nlm.nih.gov/PMC7580786
https://gup.ub.gu.se/publication/298539
http://kipublications.ki.se/Default.aspx?queryparsed=id
Volume 383
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1Lb9NAEB6RVkJcUCmv0BItEuKElayf6xOiVauqQIUIkXJbeV9taOMEHKvqv2fG3oRabfHBkr1jyfbs49vZ2e8DeG9sEeE4ogMVpjqITaKCYpTYwChOgIEThxhlW5ylJ5P4dJpMfcCt8mmV6z6x6ajNQlOMfBgSkVaC9Yt_Wv4OSDWKVle9hEYPtom6jGp1Ns1u0Ud5-OsjSJ5jE8f8ISnNLwrKUIiJRvPWmNSbz6v74ObdrMkOt2gzHh3vwFMPJNnn1vPP4JEtd0mD2edr7MLjb37Z_Dl8-TpzlhGrsV5Rb8oaZXB2gPPkhqGfjdvN0WxWMgSEbHxNu3UvGKkG4FWtKFhTMco5vHkBk-Ojn4cngVdRCHQislUQ5zoVsRhZ2kSbOYcTJDtKQxXFzmnR4EWOc5pM8xDhhOVRoY1Twmmb5SZNdfQStspFaV8DcwX6LrEqNxqRoEYrY0IneKGEwmPUh4_r_yi1pxgnpYsr2Sx1J6ns_PY-fNiYL1tujYcMB-gUWdpf84cM9tf-kr4NVvJfjenDu00xth5aEilKu6hbG8QsPI_78Kp17-ZVoohUMwSWZB3HbwyImbtbUs4uGoZunIQh9ErxA9sq0nnkvF5KvHVey8rKMEe8lN9v6G9dzsgQkTR2nm_-_6F78CSkeABl3CT7sLX6U9u3CJpWatC0DDyLQz6A7YOjs-8__gIdrxeE
linkProvider ProQuest
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV3dT9RAEJ8AJuoLQVQ8RVwT9cmG2-33gzGKksM7eAES3tbuR-HU6x32GsI_5d_ITLs9aQTfuLd2p5d2Z2b3t7szvwF4Y2zm4zyiPSUi7QUmVF7WD61nFCfAwIlDjKItDqLBcfDtJDxZgj9tLgyFVbZjYj1Qm6mmPfJtQURaIdoX_zg796hqFJ2utiU0GrMY2ssLXLKVH_a-oH7fCrH79Whn4LmqAp4Ok3juBamOkiDpW0oqjfMcFwy2HwnlB3mukxo_ccT4seYCp1fL_UybXCW5tnFqokj7-L_LcC_w0TUpM32HX6OrcnDb7Vg5Tk_EGNtU2X6aUUREQLSd1-bA5cmkvAne_hul2eEyree_3TVYdcCVfWos7REs2WKdaj67-JB1uL_vjukfw3A0zi0jFmU9p9Gb1ZXI2Wdcl9cVAdhhk4zNxgVDAMoOLyg7-IxRlQK8qhRtDpWMYhwvn8DxnfTvU1gppoV9BizP0FZCq1KjEXlqlDJG5AnPVKLw1-_B-7YfpXaU5lRZ45esj9bDSHa6vQfvFuKzhsvjNsEtVIos7I_JbQKbrb6k8_lS_rXQHrxeNKO30hFMVthp1cggRuJp0IONRr2LV_F9qtKRYEvcUfxCgJjAuy3F-KxmBMdFH0K9CD-wMZHOI6fVTOKt00qWVooU8Vl6s6C79XNMgojccbB-_v8PfQUPBkf7IznaOxi-gIeC9iIo2ifchJX578q-RMA2V1u1lzD4ftdueQVgb1Ck
linkToPdf http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1Nb9QwEB21Raq4ICgfXSitkYAT0a7z6RxQRVtWLVsqpFKpNxM7drvAZheyUdW_1l_HTOIsjWi5dW-JJ6vEnrGf7fF7AK9zkwU4jmhP-bH2wjxSXjaIjJcrToCBE4cYZVscxfsn4afT6HQJrtqzMJRW2faJdUedTzWtkfd9ItKK0L9437q0iC97w-3ZL48UpGintZXTaFxkZC4vcPpWvj_Yw7Z-4_vDj1939z2nMODpSCRzL0x1LEIxMHTANLEWJw9mEPsqCK3VosZSHPF-ormPQ63hQaZzq4TVJknzONYB_u8y3EuCRFCMiV1-jbrKQW-3euX4PRFv9EnlfppRdkRIFJ7XxsPlyaS8Cer-m7HZ4TWtx8LhQ3jgQCz70HjdI1gyxRrpP7tckTVY_ey27B_D6HBsDSNGZT2nnpzVquRsB-fotToAO24OZrNxwRCMsuMLOil8zkixAK8qRQtFJaN8x8sncHIn9fsUVoppYdaB2Qz9JjIqzTWiUI1Wee5bwTMlFP4GPXjX1qPUjt6cVDZ-ynqbPYplp9p78HZhPmt4PW4z3MRGkYX5PrnNYKNtL-niv5R_vbUHrxbFGLm0HZMVZlo1NoiXeBr24FnTvItXCQJS7BBYknQafmFArODdkmJ8XrOD4wQQYV-MH9i4SOeRs2om8dZZJUsj_RSxWnqzobv1Y0yGiOKx437-_w_dglUMSHl4cDR6Afd9WpagxJ9oA1bmvyvzErHbXG3WQcLg211H5R8k9VTa
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Life+Expectancy+after+Bariatric+Surgery+in+the+Swedish+Obese+Subjects+Study&rft.jtitle=The+New+England+journal+of+medicine&rft.au=Carlsson%2C+Lena+M.S&rft.au=Sj%C3%B6holm%2C+Kajsa&rft.au=Jacobson%2C+Peter&rft.au=Andersson-Assarsson%2C+Johanna+C&rft.date=2020-10-15&rft.pub=Massachusetts+Medical+Society&rft.issn=0028-4793&rft.eissn=1533-4406&rft.volume=383&rft.issue=16&rft.spage=1535&rft.epage=1543&rft_id=info:doi/10.1056%2FNEJMoa2002449&rft.externalDocID=NJ202010153831608
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0028-4793&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0028-4793&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0028-4793&client=summon